BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Pharm Country

  Daiichi Sankyo Co Ltd. Release: Data From Pooled Analyses Demonstrates Welchol, Combined With Metformin -- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults With Type 2 Diabetes

  May 16, 2008

   · 

  1 min read
• Drug Development

  Clinical Phase I Study Report of Marshall Edwards, Inc.’ Compound Triphendiol to Be Reported in American Society of Clinical Oncology Proceedings

  May 16, 2008

   · 

  1 min read
• Business

  ProMetic Life Sciences Inc. Reports Business Highlights and First Quarter Financial Results

  May 16, 2008

   · 

  1 min read
• Eurand Announces Annual General Meeting of Shareholders Date of May 30, 2008

  May 16, 2008

   · 

  1 min read
• Drug Development

  Alba Therapeutics Corporation Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease

  May 16, 2008

   · 

  3 min read
• Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008

  May 16, 2008

   · 

  8 min read
• Pharm Country

  75 Abstracts Evaluating Celgene Corporation Products to Be Presented at The 44th American Society of Clinical Oncology Meeting

  May 16, 2008

   · 

  1 min read
• Drug Development

  Seattle Genetics, Inc. Announces Upcoming SGN-35 Presentation at the American Society of Clinical Oncology Annual Meeting

  May 16, 2008

   · 

  1 min read
• Drug Development

  GlaxoSmithKline Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab)

  May 16, 2008

   · 

  8 min read
• Business

  AMDL, Inc. Announces First Quarter 2008 Results Posting Sales of $3.58 Million - Revenues from Product Sales Increased 149% to $3.5 Million - - Gross Profit Up; Net Loss Down

  May 16, 2008

   · 

  2 min read